You know, I honestly hope that you are right and that ABloc does great thing for many people.
As far as Mullan, he has a good resume but he is going there for the money. Nobody can predict what the results of further and more intensive studies will be.
My view of the studies isn't that they are a total failure. Just that they are not as good as current investors need them to be.
It will be Mullan's job to make decisions going forward that optimize the time and money spent on these studies to hopefully better understand ABloc and how it works. And hopefully he doesn't spend this company into bankruptcy. Ultimately, he is here for the $$$ and although he would like to find the holy grail of medicine...odds are that Anatabloc won't be it. Hopefully, he can prove something that one day many years from now will make this company some money.
But I stress that it is quite obvious that STSI is still years away from making that happen. Making this a horrible long investment and an easy short opportunity.
News 
Market Data 
Discover 
